Skip to main content

Sherman Mark Andrew's Form 4 filing

Dolby Laboratories, Inc. (DLB) · filed Dec 19, 2022

Accession no.
0001209191-22-062075
Filed
Dec 19, 2022
Trade date
Dec 15-19, 2022
Filing delay
4 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 8 non-derivative transactions and 3 derivative transactions. Open-market sales total $519.0K. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Sherman Mark AndrewCIK 0001256708Officer (EVP, GEN. COUN. & SECRTY)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Dec 15, 2022Class A Common StockFTax withholdingDisposed−2,510$73.17−$183,656.749,372Direct
Dec 15, 2022Class A Common StockAGrant or awardAcquired+18,299$0.00$067,671Direct
Dec 16, 2022Class A Common StockMOption exerciseAcquired+5,344$0.00F6$073,015Direct
Dec 16, 2022Class A Common StockFTax withholdingDisposed−3,574$71.07−$254,004.1869,441Direct
Dec 16, 2022Class A Common StockSSaleDisposed−2,334$70.66F8−$164,920.4467,107Direct
Dec 19, 2022Class A Common StockFTax withholdingDisposed−1,612$70.80−$114,129.665,495Direct
Dec 19, 2022Class A Common StockSSaleDisposed−4,738$69.80F10−$330,712.460,757Direct
Dec 19, 2022Class A Common StockSSaleDisposed−332$70.44F11−$23,386.0860,425Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Dec 15, 2022Class A Common StockAGrant or awardAcquired+9,149$0.00$09,149Direct
Dec 15, 2022Class A Common StockAGrant or awardAcquired+32,944$0.00$032,944Direct
Dec 16, 2022Class A Common StockMOption exerciseDisposed−5,344$0.00$00Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F6

Each performance-based restricted stock unit (PSU) represented a contingent right to receive, upon vesting, one share of Issuer Class A common stock.

Referenced by the price of 1 transaction in Table I.

F8

The shares were sold in multiple transactions at prices ranging from $70.433 to $71.11, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

Referenced by the price of 1 transaction in Table I.

F10

The shares were sold in multiple transactions at prices ranging from $69.257 to $70.20, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

Referenced by the price of 1 transaction in Table I.

F11

The shares were sold in multiple transactions at prices ranging from $70.27 to $70.70, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

Referenced by the price of 1 transaction in Table I.

Remarks

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

Read the full filing on SEC EDGAR (opens in a new tab)